Anji Pharma and Population Health partner to progress lead candidates
The biopharma company and investment firm will cooperate to progress late-stage clinical assets in diabetes and chronic idiopathic constipation.
The biopharma company and investment firm will cooperate to progress late-stage clinical assets in diabetes and chronic idiopathic constipation.
Thermo Fisher’s clinical research subsidiary, PPD, invests $59 million in sample management and testing capacity for vaccines and cell and gene therapy products with its expansion of laboratory operations in Kentucky.
The company states that its platform combines quantum-inspired physics and machine learning to accelerate drug discovery.